Cargando…

Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention

BACKGROUND: Contemporary rates of oral anticoagulant (OAC) therapy and associated outcomes among patients undergoing percutaneous coronary intervention (PCI) have been poorly described. METHODS AND RESULTS: Using data from an integrated health care system from 2009 to 2014, we identified patients on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Secemsky, Eric A., Butala, Neel M., Kartoun, Uri, Mahmood, Sadiqa, Wasfy, Jason H., Kennedy, Kevin F., Shaw, Stanley Y., Yeh, Robert W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121523/ https://www.ncbi.nlm.nih.gov/pubmed/27792650 http://dx.doi.org/10.1161/JAHA.116.004310

Ejemplares similares

Causes and predictors of early readmission after percutaneous coronary intervention among patients discharged on oral anticoagulant therapy
por: Vidula, Mahesh K., et al.
Publicado: (2018)

Association Between Claims‐Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND‐DAPT Study
por: Faridi, Kamil F., et al.
Publicado: (2023)

Predicting Residual Angina After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the OPEN‐CTO Registry
por: Butala, Neel M., et al.
Publicado: (2022)

Impact of Nutritional and Inflammation Status on Long-Term Bleeding in Patients Undergoing Percutaneous Coronary Intervention with an Oral Anticoagulant
por: Yoshida, Ruka, et al.
Publicado: (2019)

Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation
por: Zalewski, Jarosław, et al.
Publicado: (2016)

Clinical Preventability of 30‐Day Readmission After Percutaneous Coronary Intervention
por: Wasfy, Jason H., et al.
Publicado: (2014)

Improvements in Coronary Stent Design Translate to Better Real-World Outcomes
por: Butala, Neel M., et al.
Publicado: (2021)

Prognosis of Claims‐ Versus Trial‐Based Ischemic and Bleeding Events Beyond 1 Year After Coronary Stenting
por: Butala, Neel M., et al.
Publicado: (2021)

Bleeding Risk Profile in Patients on Oral Anticoagulation Undergoing Percutaneous Coronary Interventions: A Prospective 24 Months Cohort Study
por: Schukraft, Sara, et al.
Publicado: (2021)

Optimum Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation and Undergoing Percutaneous Coronary Intervention
por: Agarwal, Nayan, et al.
Publicado: (2018)

Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants
por: Goette, Andreas, et al.
Publicado: (2020)

Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Kwon, Soonil, et al.
Publicado: (2021)

Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention – real life assessment
por: Bogacki, Paweł, et al.
Publicado: (2016)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)

Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study
por: Kebernik, Julia, et al.
Publicado: (2018)

Novel Dual Therapy: A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Pradhan, Akshyaya, et al.
Publicado: (2020)

Oral antiplatelet therapy in the elderly undergoing percutaneous coronary intervention: an umbrella review
por: Biondi-Zoccai, Giuseppe, et al.
Publicado: (2020)

Variation in the Use of Orbital Atherectomy During Coronary Artery Intervention in the United States
por: Krawisz, Anna K., et al.
Publicado: (2023)

Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary Intervention
por: Li, Yulong, et al.
Publicado: (2022)

Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes?
por: De Luca, Leonardo, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes Among People Living With HIV Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
por: Parikh, Rushi V., et al.
Publicado: (2023)

A Cardiologists’ Survey on the Use of Anticoagulants and Antiplatelets in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Those Undergoing Percutaneous Coronary Intervention in India
por: Kulkarni, Namrata, et al.
Publicado: (2023)

The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes
por: Shlofmitz, Evan, et al.
Publicado: (2019)

Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry
por: Proietti, Marco, et al.
Publicado: (2017)

Quality of Life in Patients Undergoing Percutaneous Coronary Intervention
por: Tsoulou, Vasiliki, et al.
Publicado: (2023)

Young coronary artery disease in patients undergoing percutaneous coronary intervention
por: Zuhdi, AS, et al.
Publicado: (2013)

Ischemic and bleeding outcomes of triple therapy in patients on chronic anticoagulation undergoing percutaneous coronary intervention: A meta-analysis of randomized trials
por: Dahal, Khagendra, et al.
Publicado: (2019)

Contextualizing the BEST-CLI Trial Results in Clinical Practice
por: Butala, Neel M., et al.
Publicado: (2023)

Model for end‐stage liver disease Na Score predicts incident major cardiovascular events in patients with nonalcoholic fatty liver disease
por: Simon, Tracey G., et al.
Publicado: (2017)

Current Use of Oral Anticoagulants and Prognostic Analysis in Patients with Atrial Fibrillation Undergoing Coronary Stenting
por: Zhai, Heng-Bo, et al.
Publicado: (2017)

Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis
por: Capodanno, Davide, et al.
Publicado: (2020)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Pham, Son V, et al.
Publicado: (2010)

Premedication to reduce anxiety in patients undergoing coronary angiography and percutaneous coronary intervention
por: Vlastra, Wieneke, et al.
Publicado: (2018)

Depression and Anxiety in patients undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
por: Mujtaba, Syed Fayaz, et al.
Publicado: (2020)

The Rise and Fall of Anticoagulation with Bivalirudin During Percutaneous Coronary Interventions: A Review Article
por: Andreou, Constantinos, et al.
Publicado: (2017)

Anticoagulation Patterns in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention in an Academic Center
por: Rusia, Akash, et al.
Publicado: (2019)

Hyphema: A Rare Complication of Periprocedural Antiplatelets and Anticoagulants Following Percutaneous Coronary Intervention
por: Gulati, Amit, et al.
Publicado: (2021)

The MELD-Plus: A generalizable prediction risk score in cirrhosis
por: Kartoun, Uri, et al.
Publicado: (2017)

Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
por: Shoukat, Sana, et al.
Publicado: (2010)

Management of Atrial Fibrillation in Patients Undergoing Percutaneous Coronary Intervention
por: Mirra, M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_inbsjrpf2c4b35nmo4ielddif1